E
ZYUS Life Sciences Corporation ZLSCF
$0.60 -$0.06-9.09%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

09/30/2024 06/30/2024 03/31/2024 12/31/2023 09/30/2023
Net Income -26.86M -27.12M -30.36M -31.46M -17.87M
Total Depreciation and Amortization 2.19M 2.23M 2.15M 2.30M 1.55M
Total Amortization of Deferred Charges -- -- -- -- 724.90K
Total Other Non-Cash Items 14.95M 14.63M 18.06M 19.37M 7.50M
Change in Net Operating Assets 4.28M -512.80K -3.98M -3.60M -4.55M
Cash from Operations -5.45M -10.77M -14.13M -13.38M -12.66M
Capital Expenditure -174.40K -192.40K -196.90K -207.20K -265.00K
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions 0.00 0.00 3.66M 3.66M 3.64M
Divestitures -- -- -- -- --
Other Investing Activities -- -- -- -- --
Cash from Investing -174.40K -192.40K 3.47M 3.46M 3.37M
Total Debt Issued 700.00K 400.00K 18.79M 21.24M 23.58M
Total Debt Repaid -3.36M -1.31M -4.39M -4.11M -3.93M
Issuance of Common Stock 3.31M -- -- -- 0.00
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing 476.00K -679.70K 10.73M 12.75M 14.60M
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -5.14M -11.64M 60.80K 2.82M 5.32M
Weiss Ratings